CTRI/2023/10/059260尚未招募Unknown
Validation of PREDICT V 2.2 Breast Cancer Prognostication Tool In Patients attending a Tertiary Cancer Care Centre In Kerala. - NI
I0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Non metastatic invasive carcinoma of breast
- •after primary breast conservation surgery or modified radical mastectomy
- •Breast cancer patients who were diagnosed and treated at Caritas cancer institute between 1 st January 2015 and 31 st December2019
排除标准
- •Patients with bilateral breast cancer/ ductal carcinoma insitu/ lobular carcinoma in situ
- •Patients who underwent neoadjuvant chemotherapy or endocrine therapy
- •Patient who has breast cancer as second primary
- •Patients with incomplete medicalrecords or missing data necessary for PREDICT tool calculation
研究者
相似试验
招募中
不适用
Clinical performance study of breast cancer prognostic diagnosticsGenesWell™ BCT in Korean patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative early breast cancerKCT0004263Samsung Medical Center500
尚未招募
不适用
Studying the risk factors for breast cancer in Indian women.ÂCTRI/2019/10/021652Tata Memorial Centre
招募中
2 期
Pre-operative phase II trial for breast cancer with nivolumab in combination with novel IO (BELLINI trial)breast cancerNL-OMON54814ederlands Kanker Instituut90
进行中（未招募）
1 期
Pre-operative study for breast cancer with nivolumab in combination with other therapyMedDRA version: 21.1Level: LLTClassification code 10006188Term: Breast cancer female NOSSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: LLTClassification code 10006194Term: Breast cancer NOS stage ISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: LLTClassification code 10006195Term: Breast cancer NOS stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: LLTClassification code 10006196Term: Breast cancer NOS stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-004188-30-NLKI-AV90
已完成
不适用
Validation study of the prognostic and predictive value of TP53 signature for breast cancer Collateral researchBreast cancerJPRN-UMIN000042055Japan Agency for Medical Research and Development107